Financial reports
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
3 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
18 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
12 Mar 24
8-K
Innovid Reports Q4 and Fiscal Year 2023 Financial Results
27 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
5 Feb 24
8-K
Regulation FD Disclosure
30 Nov 23
8-K
Innovid Reports Q3 2023 Financial Results
8 Nov 23
8-K
Innovid Appoints New CFO and Announces Preliminary Unaudited Q3 2023 Revenue Exceeding Guidance
16 Oct 23
8-K
Innovid Reports Q2 2023 Financial Results
8 Aug 23
8-K
Departure of Directors or Certain Officers
6 Jul 23
8-K
Other Events
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
8 Jun 23
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
14 Sep 23
S-1/A
IPO registration (amended)
12 Sep 23
POS AM
Prospectus update (post-effective amendment)
19 May 23
424B3
Prospectus supplement
9 May 23
424B3
Prospectus supplement
9 May 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
14 Nov 22
424B3
Prospectus supplement
14 Nov 22
424B3
Prospectus supplement
10 Aug 22
Other
EFFECT
Notice of effectiveness
20 Sep 23
EFFECT
Notice of effectiveness
30 May 23
EFFECT
Notice of effectiveness
4 May 22
CORRESP
Correspondence with SEC
29 Apr 22
UPLOAD
Letter from SEC
25 Apr 22
EFFECT
Notice of effectiveness
7 Apr 22
EFFECT
Notice of effectiveness
3 Jan 22
CORRESP
Correspondence with SEC
29 Dec 21
UPLOAD
Letter from SEC
27 Dec 21
EFFECT
Notice of effectiveness
12 Nov 21
Ownership